ESTUDIO RETROSPECTIVO DEL MANEJO DE PACIENTES CON CÁNCER COLORRECTAL METASTÁSICO RESISTENTES A UNA PRIMERA LÍNEA BASADA EN OXALIPLATINO.

Dades bàsiques

Protocol:
SAN-QUI-2012-01
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2013
Any de finalització:
2016
ESTUDIO OBSERVACIONAL NACIONAL

Objectius del projecte

Observaciones: Estado Comité: FINALIZADO

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

SANOFI AVENTIS S.A

Resultats de l'Assaig Clínic


A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond

Gomez-Martin, C; (...); Lordick, F

Review. 10.1016/j.canlet.2014.05.019. 2014


A Phase I, Dose-Finding Study of Sorafenib in Combination with Gemcitabine and Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Grupo Espanol Multidisciplinario en Cancer Digestivo (GEMCAD) Study

Aparicio, J; (...); Maurel, J

Article. 10.1371/journal.pone.0082209. 2014

  • Open Access.

Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution

Bruixola, G; (...); Aparicio, J

Article. 10.5301/tj.5000344. 2015


Clinical Aspects of Usher Syndrome and the USH2A Gene in a Cohort of 433 Patients

Blanco-Kelly F; (...); Ayuso C

Article. 10.1001/jamaophthalmol.2014.4498. 2015


ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

Vargas, T; (...); de Molina, AR

Article. 10.18632/oncotarget.3130. 2015

  • Open Access.

Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

Feliu, J; (...); Maurel, J

Article. 10.1371/journal.pone.0116527. 2015

  • Open Access.

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

Fernandez-Martos C; (...); Minsky BD

Article. 10.1093/annonc/mdv223. 2015


First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

Feliu, J; (...); Maurel, J

Article. 10.1038/bjc.2014.346. 2014


Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.

Diaz Beveridge R; (...); Montalar J

Article. 10.6092/1590-8577/1570. 2014


Monosegment ALPPS: A new variant of the techniques for rapid hepatic regeneration. Critical review of the initial results of our series

Montalvá Orón EM; (...); López-Andújar R

Article. 10.1016/j.ciresp.2015.02.011. 2015


Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience

Diaz-Beveridge, R; (...); JORGE APARICIO URTASUN

Article. 10.1097/MPH.0000000000000339. 2015


Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer.

Carrato A; (...); Aranda E

Article. 10.1007/s12094-012-0993-x. 2013


Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer

Oldenburg, J; (...); Spanish Germ Cell Canc Grp SGCCG

Review. 10.1093/annonc/mdu514. 2015


Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy

Custodio, A; (...); Feliu, J

Article. 10.1158/1535-7163.MCT-13-1109. 2014


Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study

Custodio, A; (...); Feliu, J

Article. 10.1093/annonc/mdt546. 2014


Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature

Bruixola G; (...); Aparicio J

Review. 10.1016/j.lungcan.2014.07.012. 2014


Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial

Fernandez-Martos, C; (...); Pericay, C

Editorial Material. 10.1634/theoncologist.2014-0233. 2014


Primary Mesenteric Undifferentiated Pleomorphic Sarcoma Masquerading as a Colon Carcinoma: A Case Report and Review of the Literature.

Diaz-Beveridge R; (...); Aparicio J

Article. 10.1155/2015/532656. 2015


Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Aparicio J; (...); Germà JR

Article. 10.1093/annonc/mdu437. 2014


Prognostic significance of thromboembolic events in chemotherapy-treated germ cell tumors.

Gonzalez-Billalabeitia, Enrique; (...); Germa-Lluch, Jose R.

Meeting Abstract. 10.1200/jco.2015.33.15_suppl.4536. 2015


Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience

Imedio ER; (...); Salcedo JM

Article. 10.1007/s12032-014-0948-x. 2014


SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

Aranda, E; (...); Garcia-Carbonero, R

Article. 10.1007/s12094-015-1434-4. 2015

  • Open Access.

Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base

Girones, R; (...); SGCCG

Article. 10.1007/s12094-014-1179-5. 2014


Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre

Salvador, C.; (...); Aparicio, J.

Meeting Abstract. 10.1016/S0959-8049(16)31204-7. 2015


Compartir el projecte